Research Article
Association of Side-Branch Treatment and Patient Factors in Left Anterior Descending Artery True Bifurcation Lesions: Analysis from the GRAND-DES Pooled Registry
Table 1
Baseline characteristics according to SB treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are mean ± SD, median (interquartile ranges, 25th–75th), or n (%) (per-patient analysis). Calculated in 904 patients with available values for creatinine and ejection fraction. SB, side-branch; BMI, body mass index; CVA, cerebrovascular accident; PAD, peripheral artery disease; FHx, family history; CHD, coronary heart disease; MI, myocardial infarction; ACS, acute coronary syndrome; LV, left ventricle; EF, ejection fraction; Cr, creatinine; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft surgery; 3VD, three-vessel disease; IVUS, intravascular ultrasound; GP, glycoprotein; DAPT, dual antiplatelet therapy; RAS, renin-angiotensin system; ACEF, age, creatinine, and ejection fraction. |